Completed Economics & Business Cancer

Oi

Funder InnovateUK (part of UKRI)
Recipient organisation Oxford Innovations Services LTD
Funding £6.4M
Period Mar 2022 — Mar 2025

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by InnovateUK.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

Ini
EoI
Omice
A randomised controlled trial assessing the clinical and cost-effectiveness of Endovascular vs. Open revascularisation in severe oCClusive aorto-iliac disease. The EVOCC Trial
Iot-sfc

Original classification

Collaborative R&D

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.